FI881238A - Farmaceutisk beredning. - Google Patents

Farmaceutisk beredning. Download PDF

Info

Publication number
FI881238A
FI881238A FI881238A FI881238A FI881238A FI 881238 A FI881238 A FI 881238A FI 881238 A FI881238 A FI 881238A FI 881238 A FI881238 A FI 881238A FI 881238 A FI881238 A FI 881238A
Authority
FI
Finland
Prior art keywords
beredning
farmaceutisk
farmaceutisk beredning
Prior art date
Application number
FI881238A
Other languages
English (en)
Finnish (fi)
Other versions
FI881238A0 (fi
Inventor
Curt Henry Appelgren
Eva Christina Eskilsson
Soeren Ingemar Johansson
Original Assignee
Lejus Medical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lejus Medical Ab filed Critical Lejus Medical Ab
Publication of FI881238A0 publication Critical patent/FI881238A0/fi
Publication of FI881238A publication Critical patent/FI881238A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/49—Cinchonan derivatives, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI881238A 1987-03-16 1988-03-15 Farmaceutisk beredning. FI881238A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8701077A SE460946B (sv) 1987-03-16 1987-03-16 En multipel-unit-dos komposition av kinidinglukonat

Publications (2)

Publication Number Publication Date
FI881238A0 FI881238A0 (fi) 1988-03-15
FI881238A true FI881238A (fi) 1988-09-17

Family

ID=20367877

Family Applications (1)

Application Number Title Priority Date Filing Date
FI881238A FI881238A (fi) 1987-03-16 1988-03-15 Farmaceutisk beredning.

Country Status (5)

Country Link
EP (1) EP0287536A1 (sv)
DK (1) DK139388A (sv)
FI (1) FI881238A (sv)
NO (1) NO881152L (sv)
SE (1) SE460946B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202128A (en) * 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
US5196203A (en) * 1989-01-06 1993-03-23 F. H. Faulding & Co. Limited Theophylline dosage form
ES2077023T3 (es) * 1989-03-10 1995-11-16 Yamanouchi Pharma Co Ltd Material de recubrimiento que controla la liberacion de un medicamento para formulaciones de actividad prolongada.
US4983401A (en) * 1989-05-22 1991-01-08 Kinaform Technology, Inc. Sustained release pharmaceutical preparations having pH controlled membrane coatings
SG42869A1 (en) * 1992-08-05 1997-10-17 Faulding F H & Co Ltd Pelletised pharmaceutical composition
US7122207B2 (en) 1998-05-22 2006-10-17 Bristol-Myers Squibb Company High drug load acid labile pharmaceutical composition
UA69413C2 (uk) * 1998-05-22 2004-09-15 Брістол-Майерс Сквібб Компані Фармацевтична композиція, яка містить серцевину та ентеросолюбільну оболонку, фармацевтична композиція у вигляді сфероїдальних гранул, спосіб одержання сфероїдальних гранул та спосіб одержання фармацевтичної композиції
DE10211289A1 (de) 2002-03-14 2003-09-25 Basf Ag Kombination von Polyvinylacetat von wasserunlöslichen, säureunlöslichen oder alkaliunlöslichen Polymeren zur Hestellung von Filmüberzügen mit sehr kontrollierter Freisetzung und hoher Stabilität

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
SE8003805L (sv) * 1980-05-21 1981-11-22 Haessle Ab En farmaceutisk beredning med forbettrade utlosningsegenskap
EP0113373B1 (en) * 1982-07-09 1991-08-28 Key Pharmaceuticals, Inc. Sustained release quinidine dosage form
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
IE59287B1 (en) * 1984-02-10 1994-02-09 Benzon Pharma As Diffusion coated multiple-units dosage form

Also Published As

Publication number Publication date
DK139388D0 (da) 1988-03-15
SE460946B (sv) 1989-12-11
EP0287536A1 (en) 1988-10-19
FI881238A0 (fi) 1988-03-15
SE8701077L (sv) 1988-09-17
NO881152L (no) 1988-09-19
SE8701077D0 (sv) 1987-03-16
DK139388A (da) 1988-12-08
NO881152D0 (no) 1988-03-16

Similar Documents

Publication Publication Date Title
DE3880632D1 (de) Kuevette.
DE3881291D1 (de) Sehapparat.
DE3862564D1 (de) Erdanker.
FI77952B (fi) Ljusbaogsrelae.
DE3867976D1 (de) Polymergebundene antioxydationsmittel.
DE3883705D1 (de) Alkenylbicyclohexane.
DE3876873D1 (de) Weblitzenuebergabevorrichtung.
DE3785663D1 (de) Loetgeraet.
DE3876304D1 (de) Polysilacylobutasilazane.
DE3882446D1 (de) Polydisilacyclobutasilazane.
DE3870513D1 (de) Tennisball.
DE3888991D1 (de) Aminokohlenwasserstoff-substituierte Ketoximosilane.
DE3877421D1 (de) Polyamidbenzazole.
FI77055B (fi) Vaermegradient-inkubator.
DE3879348D1 (de) Fm-cw-radargeraet.
DE3878970D1 (de) Praeparative chromatographiesaeule.
DE3862309D1 (de) Aminomethyltetrahydrofurane.
FI86994B (fi) Korrosionsfasta vismut innehaollande zirkoniumlegeringar.
DE3861694D1 (de) Cyclopropancarboxamide.
DE3860710D1 (de) Exklusiv-oder-schaltung.
DE3860307D1 (de) 2-aminomethyltetrahydrofurane.
DE3866770D1 (de) Gerbstoff.
DE3873615D1 (de) Polycyanoarylthioether.
DE3879625D1 (de) Laseroszillator.
DE3867805D1 (de) Paraocclusaler loeffel.

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: LEJUS MEDICAL AKTIEBOLAG